China: Sequoia-backed biopharma startup JHL Biotech raises $106m

Photo by Martin Lopez from Pexels

JHL Biotech, a biopharmaceutical company backed by Sequoia Capital, has raised $106 million by selling convertible bonds in a round led by Hong Kong-based private equity firm VMS Investment Group, and joined by existing shareholders.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.